Floatz logo

Tenecteplase

Medium Vessel Occlusions

Beijing Tiantan Hospitalprotein_peptidePhase 3Active
B
60/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
45/ 100
Competitive Position
95/ 100

Competitive context

7 Active assets in the Medium Vessel Occlusions cohort.

Asset / SponsorPhaseRating
3-N-BUTYLPHTHALIDE
The Second Hospital of Hebei Medical University
Phase 4BB
Recombinant Human Plasminogen Activator
The First Affiliated Hospital with Nanjing Medical University
Phase 3B
WARFARIN
Columbia University
Phase 3B
ROPIVACAINE
University of Sao Paulo General Hospital
Phase 3B
Apixaban
Columbia University
Phase 3B

View all 10 →

Same molecule, other indications

Tenecteplase is also rated in:

basilar artery occlusionDormant
BBB
Indicative ·
75 / 100
View asset →
ischemic strokeDormant
BBB
Indicative ·
72 / 100
View asset →
stroke disorderDormant
BBB
Indicative ·
72 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →